Early Screening of Pancreatic Cancer Immunotherapy Target Candidates
It has proven difficult to accurately identify the biological targets of cancer, which are necessary for the development of successful therapeutics including novel immunotherapies, such as those based on chimeric antigen receptor (CAR) T cells.
Download this app note to discover a solution that can:
- Enable effective dissociation of human and mouse tumors while preserving cell viability
- Purify tumor cells regardless of their marker expression
- Provide high-quality target screening and analysis
